Primary and Secondary Hemostasis in Elective Coronary Artery Bypass Graft Surgery
NCT ID: NCT00825981
Last Updated: 2010-07-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100 participants
OBSERVATIONAL
2009-01-31
2010-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mechanistic Study of Bleeding Risk in Coronary Patients With Cerebrovascular Disease
NCT02316119
Prediction of Bleeding and Transfusion Outcomes and Assessment of Perioperative Platelet Reactivity in Cardiac Surgery
NCT02277379
Blood Cell Adhesion to Arterial Filters During Cardiac Surgery
NCT03882593
Auto-administered Questionnaire by Screening of Disorder of the Haemostasis in Preoperative
NCT02886117
Thrombelastogram in Patients Receiving Antiplatelet Medication Undergoing Cardiac Surgery
NCT00778492
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
coronary artery bypass graft
patients undergoing elective coronary artery bypass graft with or without cardiopulmonary bypass
screening coagulation abnormalities
if specific coagulation abnormalities are observed which increase patient's risk of bleeding, appropriate treatment will start
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
screening coagulation abnormalities
if specific coagulation abnormalities are observed which increase patient's risk of bleeding, appropriate treatment will start
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Cliniques Universitaires saint Luc
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cliniques Universitaires Saint Luc
Brussels, Brussels Capital, Belgium
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Hertfelder HJ, Bos M, Weber D, Winkler K, Hanfland P, Preusse CJ. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting. Semin Thromb Hemost. 2005;31(4):426-40. doi: 10.1055/s-2005-916678.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2008/10DEC/350
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.